Latest News

Halting immune response could save brain cells after stroke

A new study in animals shows that using a compound to block the body?s immune response greatly reduces disability after a stroke. The study also showed that particular immune cells -- CD4+ T-cells produce a mediator, called interleukin (IL) -21 that can cause further damage in stroke tissue. Moreover, normal mice, ordinarily killed or disabled by an ischemic stroke, were given a shot of a compound that blocks the action of IL-21. Brain scans and brain sections showed that the treated mice suffered little or no stroke damage.
View full story

Post your comment.


  • Gene variants involved in stress responses affect 'post-concussive' symptoms

  • Tracing a path toward neuronal cell death

  • Income-based school assignment policy influences diversity, achievement

  • Low sugar diet makes foods taste sweeter but does not change preferred level of sweetness

  • Reduced blood flow seen in brain after clinical recovery of acute concussion

  • Newly evolved, uniquely human gene variants protect older adults from cognitive decline

  • Parental absence affects brain development in children

  • Aspirin targets key protein in neurodegenerative diseases

  • Could fish have consciousness? 'Emotional fever' experiment suggests they might

  • Threats against children during the separation process for women in abusive relationships